The associate professor of medicine from University of Pennsylvania discussed advantages of huCART19-IL18 in NHL and CLL.
Jakub Svoboda, MD
Advertisement
Articles by Jakub Svoboda, MD
The associate professor of medicine from University of Pennsylvania discussed updated data on huCART19-IL18 presented at the ASH 2022 meeting.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Quarter Century Update: Thoughts on Reducing Costs of Goods
3
CGTLive®’s Weekly Rewind – October 31, 2025
4
Quarter Century Update: Future Predictions for the Field
5
